Personalized Cancer Treatment Study for Adults with Pancreatic Cancer Using Molecular Tumor Profiling

What this Trial Is About

This research aims to explore precision oncology for adults with pancreatic cancer by collecting and analyzing data to understand how personalized treatments based on molecular tumor profiling work. The study evaluates how well molecular testing predicts patient responses to targeted therapies and assesses outcomes like tumor response, time to treatment failure, survival, and treatment tolerability. The study is observational and non-therapeutic, examining patient medical records both retrospectively and prospectively. It focuses on examining results from molecular profiling obtained through standard care to guide targeted therapy decisions. Approved targeted therapies based on each patients genomic profile are considered by investigators for potential anti-tumor treatment. Participants will have their demographic and clinical data reviewed, including tumor response and survival outcomes. Researchers will monitor how many subjects receive targeted therapy over five years. The study involves no direct intervention or treatment administration by the research team. Participation includes data collection from medical records and ongoing tracking of treatment outcomes to better understand personalized therapy in pancreatic cancer.

Determining Individualized Cancer Therapy in Pancreatic Cancer